Well, yes. That's what i deem to be balanced. He's bullish on the stock's potential, but has articulated the negative aspects. Both sides of the ledger = balanced.
I didn't mean to hit a nerve huggy.. i'm watching with interest as the tech is interesting, upside is there.. and as echoed in these hallowed HC chambers, "gold standard".
However any further delays on fda approval will bring things to a head rather quickly with the rate of cash burn (hence the wage cost implication) and then the need to raise further capital to keep the lights on (or more accurately, the CEO & co in 7 cushy figures).
That part of the equation is what irks me, what's he compensating for? Is it a stature thing? There's plenty of that going around. Not the kind of lead-by-example General folks are inspired to follow into the battlefield, moreso one calling the shots from a safe distance (while possibly getting blown by an attractive concubine- and fair play to him.. ) whilst sending the front line soldiers into peril.
And promising or not, huge potential or not, in this market with these macro headwinds.. companies are getting bent over on capital raises, so don't kid yourself into thinking one will be done at a premium to current SP. Need some positive news catalysts pre collection plate going around again or this is sub 20c
Add to My Watchlist
What is My Watchlist?
